Mark Talamonti to Genetic Markers
This is a "connection" page, showing publications Mark Talamonti has written about Genetic Markers.
Connection Strength
0.176
-
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients. Br J Dermatol. 2017 Aug; 177(2):489-496.
Score: 0.134
-
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 2012 Oct; 61(10):1454-64.
Score: 0.023
-
Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009 Feb 01; 99(2):119-22.
Score: 0.019